Cargando…

Convergence of EGFR glioblastoma mutations: evolution and allostery rationalizing targeted therapy

EGFR mutations display striking organ-site asymmetry and heterogeneity. We have shown that structurally diverse extracellular mutations, typical of glioblastomas, converge to a similar intermediate conformation, which can be synergistically targeted extra- and intracelullarly by antibody mAb806 and...

Descripción completa

Detalles Bibliográficos
Autor principal: Orellana, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736128/
https://www.ncbi.nlm.nih.gov/pubmed/31528699
http://dx.doi.org/10.1080/23723556.2019.1630798